InvestorsHub Logo
icon url

itsthebox1

05/31/16 6:33 PM

#2890 RE: Inoviorulez #2889

Yah, sales of $1bil during 2030 seems really low
icon url

tjguy

05/31/16 8:23 PM

#2893 RE: Inoviorulez #2889

Totally wrong. no way its only peak sales of $1.28 billion. The market for adjunct therapy is $5 billion and the monotherapy is $11 billion.



Agreed. The peak sales should be far higher! Some have mentioned 1 billion in sales within a year or two. If the drug is as effective as claimed, why not?